Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286492 (2-Methoxy-6-(6-methoxy-4-((6-(4-methoxytetrahydro-...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286477 (4-(6-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286479 (US9518064, Example 98) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.290 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286495 ((S)-2-(1-Fluoroethyl)-6-(4-((6-(4-fluorotetrahydro...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.310 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286494 (6-(4-((6-(4-Fluorotetrahydro-2H-pyran-4-yl)pyridin...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.350 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286478 (6-(4-((2-(2-fluoropyridin-4-yl)pyrimidin-4-yl)meth...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.360 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286421 (US9518064, Example 37) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.360 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286493 ((S)-2-(1-Fluoroethyl)-6-(6-methoxy-4-((6-(4-methox...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.360 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286420 (US9518064, Example 36) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.380 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286464 (6-(4-((3-Fluoro-5-(2-methoxypyrimidin-5-yl)benzyl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.390 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286491 ((S)-4-(6-(((2-(2-(1-Fluoroethyl)imidazo[2,1-b][1,3...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.410 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286490 (4-(6-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.450 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286424 (US9518064, Example 40) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.470 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286418 (US9518064, Example 34) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.480 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286419 (US9518064, Example 35) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.490 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286453 (US9518064, Example 71) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286423 (US9518064, Example 39) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.530 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286436 (US9518064, Example 52) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.560 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286467 (2-Methoxy-6-(6-methoxy-4-((3-(5-(1-((tetrahydro-2H...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.560 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286416 (US9518064, Example 32) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.570 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286449 (6-(4-((3-(6-Chloropyridin-3-yl)-5-methoxybenzyl)ox...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.570 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286427 (US9518064, Example 43) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.600 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286417 (US9518064, Example 33) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.670 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286422 (US9518064, Example 38) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.680 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286439 (US9518064, Example 55) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.690 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286476 (US9518064, Example 95) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.690 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286431 (US9518064, Example 47) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.690 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286474 (US9518064, Example 93) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.710 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286483 (US9518064, Example 102) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.720 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286473 (2-Methoxy-6-(6-methoxy-4-((3-(tetrahydro-2H-pyran-...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.720 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286440 (US9518064, Example 56) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.740 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286481 (US9518064, Example 100) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.760 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286470 (US9518064, Example 89) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.790 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286446 (6-(4-((3-Fluoro-5-(5-methoxypyridin-2-yl)benzyl)ox...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.840 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286485 (US9518064, Example 104) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.850 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286482 (2-Methoxy-6-(6-methoxy-4-((2-phenylpyrimidin-4-yl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.920 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286460 (US9518064, Example 78) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.950 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286445 (US9518064, Example 61) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286429 (US9518064, Example 45) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.03 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286432 (US9518064, Example 48) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.03 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286426 (US9518064, Example 42) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.05 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286387 (2-Methoxy-6-(6-methoxy-4-((3-(pyrimidin-5-yl)benzy...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286486 (US9518064, Example 105) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.06 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286448 (6-(4-((5-(Furan-3-yl)pyridin-3-yl)methoxy)-6-metho...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.08 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286488 (6-(6-Chloro-4-((3-(2-methoxypyrimidin-5-yl)benzyl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.09 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286469 (US9518064, Example 88) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286468 (1-(6-(3-(((6-Methoxy-2-(2-methoxyimidazo[2,1-b][1,...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.11 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286435 (US9518064, Example 51) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.19 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286428 (US9518064, Example 44) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.21 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 4 (Homo sapiens (Human)) | BDBM286442 (US9518064, Example 58) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.22 | n/a | n/a | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company; Universite De Montreal US Patent | Assay Description The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L... | US Patent US9518064 (2016) BindingDB Entry DOI: 10.7270/Q2TT4SZX | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 131 total ) | Next | Last >> |